Xtant Medical to Issue First Quarter 2023 Financial Results on May 4, 2023
Xtant Medical Holdings (NYSE American: XTNT) will announce its Q1 2023 financial results on May 4, 2023, before market open.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Xtant Medical Holdings (NYSE American: XTNT) will announce its Q1 2023 financial results on May 4, 2023, before market open. A conference call will follow at 9:00 AM ET, led by CEO Sean Browne and CFO Scott Neils, to discuss the results. Interested parties can join through dial-in numbers or via a webcast registration link provided in the release. Xtant Medical specializes in medical technology, focusing on orthobiologics and spinal implant systems for spinal fusion procedures. The company emphasizes integrity and dedication in serving its customers. For further information, a replay of the call will be accessible on the company's website after the live event.
Details
News Market Reaction – XTNT
The recorded move for XTNT in the trading session of this news was +3.68%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BELGRADE, Mont., April 27, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the first quarter ended March 31, 2023, before the open of the financial markets on Thursday, May 4, 2023.
Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will host a conference call on Thursday, May 4 at 9:00 AM ET to review results.
Conference Details
Conference Call Date: Thursday, May 4, 2023 - 9:00 AM ET
Conference dial-in: 877-407-6184
International dial-in: 201-389-0877
Conference Call Name: Xtant Medical Q1 2023 Financial Results
Webcast Registration: Click Here
Following the live call, a replay will be available on the Company’s website, www.xtantmedical.com, under “Investor Info.”
About Xtant Medical Holdings, Inc.
Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.
The symbols ™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.
Investor Relations Contact
David Carey
Lazar FINN Partners
Ph: 212-867-1762
Email: david.carey@finnpartners.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.